Children's Hospital Boston
Boston, Massachusetts, 02115, United States
NCT Number: NCT00979303
The purpose of this study is to determine whether the additional use of non-fluoroscopic imaging modalities can decrease the use of radiation exposure during standard ablation procedures for supraventricular tachycardia (SVT) in children.
Looking for future studies?
Notify Me8 year–21 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
The standard of care for children undergoing SVT ablation is radiation (fluoroscopy) to see the heart. Non fluoroscopic imaging tools have been utilized for adult atrial fibrillation procedures. These tools utilize magnetic fields to visualize the heart without using radiation. The purpose of this study was to determine if these 3D mapping tools could reduce radiation exposure during SVT ablation procedures could be performed using these 3D tools.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients assigned to the intervention group will receive both intracardiac echocardiography as well as a 3D navigational system in addition to fluoroscopy during their ablation procedure.
Other names: AcuNav Intracardiac Echocardiography, NavX 3D navigational system, CARTO 3D navigational system
Time frame: During the Ablation procedure
Total fluoroscopy time in minutes
Time frame: During Ablation Procedure
Total radiation exposure measured in mGy
Boston Children's Hospital
Other
The Adjunct Use of Non-Fluoroscopic Imaging Devices to Decrease Radiation Exposure During Ablation of Supraventricular Tachycardia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07554170
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Bandar Abbas, Hormozgan, Iran
View Trial DetailsNCT04837261
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Jyväskylä, Central Finland, Finland
View Trial DetailsNCT01426425
Arrhythmias, Cardiac, AtrioVentricular Nodal Reentrant Tachycardia
Phoenix, Arizona, United States
View Trial DetailsNCT02216240
Arrhythmias, Cardiac, Cardiac Conduction System Disease
London, United Kingdom
View Trial Details